Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease

BACKGROUND: A residual risk of cardiovascular disease tends to persist despite standard prevention therapy with statins. This may stem partly from increased oxidized low-density lipoprotein (LDL) levels. However, how oxidized LDL can be further reduced beyond statin therapy in high-risk diabetes pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Morihiro, Tamura, Ritsu, Kanno, Kotaro, Segawa, Takatsugu, Kinoshita, Haruyuki, Nishimoto, Orie, Nishiyama, Hirohiko, Kawamoto, Toshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029151/
https://www.ncbi.nlm.nih.gov/pubmed/24314067
http://dx.doi.org/10.1186/1758-5996-5-77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029151/
https://www.ncbi.nlm.nih.gov/pubmed/24314067
http://dx.doi.org/10.1186/1758-5996-5-77

Ejemplares similares